GGrantIndex
← Leaderboards

Adam R. Abate

University Of California, San Francisco

$16,378,110
Attributed
$26,438,015
Total exposure
15
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY201325
$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,438,015 · 15

By mechanism

R01$19,087,910 · 7
DP2$2,370,000 · 1
R42$1,654,892 · 1
U01$1,558,807 · 1
R21$1,287,611 · 3
R41$478,795 · 2

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Microfluidics

Research focus

MicrofluidicsTechnologySamplingCellsGenomicsInfectionVirusDigitalGenomePropertyInvestigationDetectionNucleic AcidsCostBaseComplexOrganismBiological MarkersInstrumentDiagnosticProtocols DocumentationGene Expression ProfileEquipmentBiology

Grant awards (42)

Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users$1,557,466
R01 · FY2025 · DA
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning$617,550
R01 · FY2025 · AI · contact PI
Gigapixel Next-Generation-Sequencing: An Ultra-Sensitive Diagnostic for Infections of the CNS$610,589
R01 · FY2025 · AI · contact PI
Identification of Regulatory Mechanisms Operating in Rare Pathogenic Astrocyte Subsets in Multiple Sclerosis with a Novel Genomic Technology$573,663
R01 · FY2025 · NS · contact PI
Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users$1,560,507
R01 · FY2024 · DA
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV$741,176
R01 · FY2024 · AI
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning$629,850
R01 · FY2024 · AI · contact PI
Gigapixel Next-Generation-Sequencing: An Ultra-Sensitive Diagnostic for Infections of the CNS$610,443
R01 · FY2024 · AI · contact PI
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology$556,336
R01 · FY2024 · NS · contact PI
A non-invasive metabolic sensor for improving success in IVF$242,250
R21 · FY2024 · HD · contact PI
Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users$1,630,854
R01 · FY2023 · DA
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution$817,050
R42 · FY2023 · GM
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV$745,775
R01 · FY2023 · AI
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning$623,700
R01 · FY2023 · AI · contact PI
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology$573,422
R01 · FY2023 · NS · contact PI
A non-invasive metabolic sensor for improving success in IVF$201,875
R21 · FY2023 · HD · contact PI
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution$837,842
R42 · FY2022 · GM
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV$750,282
R01 · FY2022 · AI
Gigapixel digital PCR in Giant Unilamellar Vesicles$619,168
R01 · FY2022 · EB · contact PI
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV$754,701
R01 · FY2021 · AI
Gigapixel digital PCR in Giant Unilamellar Vesicles$621,029
R01 · FY2021 · EB · contact PI
Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering$253,795
R41 · FY2021 · GM
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV$778,783
R01 · FY2020 · AI
Gigapixel digital PCR in Giant Unilamellar Vesicles$627,044
R01 · FY2020 · EB · contact PI
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING$455,980
U01 · FY2020 · AI · contact PI
A platform for engineering peptide ligase for building next generation peptide therapeutics.$225,000
R41 · FY2020 · GM · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$639,634
R01 · FY2019 · EB · contact PI
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING$291,071
U01 · FY2019 · AI · contact PI
Accurate and unbiased single cell sequencing with digital droplet MDA$579,713
R01 · FY2018 · HG · contact PI
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING$330,664
U01 · FY2018 · AI · contact PI
Accurate and unbiased single cell sequencing with digital droplet MDA$579,299
R01 · FY2017 · HG · contact PI
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING$481,092
U01 · FY2017 · AI · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$350,433
R01 · FY2017 · EB · contact PI
Accurate and unbiased single cell sequencing with digital droplet MDA$713,363
R01 · FY2016 · HG · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$350,433
R01 · FY2016 · EB · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$343,336
R01 · FY2015 · EB · contact PI
Microfluidic immunoprofiling for biomarker discovery in rheumatoid arthritis$2,370,000
DP2 · FY2014 · AR · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$349,361
R01 · FY2014 · EB · contact PI
Accurate, long-read sequencing with droplet-microfluidic barcoding$197,552
R21 · FY2014 · HG · contact PI
Advancing Whole-Organism Screening for Chemical Modifiers of the Brain$192,159
R21 · FY2014 · NS
Accurate, long-read sequencing with droplet-microfluidic barcoding$235,625
R21 · FY2013 · HG · contact PI
Advancing Whole-Organism Screening for Chemical Modifiers of the Brain$218,150
R21 · FY2013 · NS